| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 392,644 | 380,359 | 371,674 | 415,092 | | Cost of Revenue | (84,032) | 202,229 | 199,677 | 98,450 | | | Gross Profit | 476,676 | 178,130 | 171,997 | 316,642 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 374,372 | 79,716 | 85,554 | 184,442 | | Non Recurring | 17,170 |
-
|
-
|
-
| | Others | 19,023 | 35,701 | 34,629 | 35,136 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 66,111 | 62,713 | 51,814 | 97,064 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 160 | 182 | 396 | 1,345 | | Earnings Before Interest And Taxes | 66,271 | 62,895 | 52,210 | 98,409 | | Interest Expense | 8,773 | 8,714 | 8,619 | 4,730 | | Income Before Tax | 57,498 | 54,181 | 43,591 | 93,679 | | Income Tax Expense | 21,470 | 20,708 | 17,607 | 35,513 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 36,028 | 33,473 | 25,984 | 58,166 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 36,028 | 33,473 | 25,984 | 58,166 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $36,028 | $33,473 | $25,984 | $58,166 |
|
0.31% Nasdaq 
0.05%
Income Statement
